Controlled release coprecipitates: formulation considerations
- 30 November 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 37 (1-2), 131-141
- https://doi.org/10.1016/0168-3659(95)00073-h
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Optimization of process variables for the preparation of ibuprofen coprecipitates with eudragit S100International Journal of Pharmaceutics, 1994
- Physical Characterization and Dissolution Properties of lbuprofen:Eudragit CoprecipitatesJournal of Pharmaceutical Sciences, 1991
- In vitro and in vivo evaluation of sustained release suspensions of ibuprofenInternational Journal of Pharmaceutics, 1991
- Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intakeInternational Journal of Pharmaceutics, 1989
- Controlled-Release Theophylline Tablet Formulations Containing Acrylic Resins, III. Influence of Filler Excipient.Drug Development and Industrial Pharmacy, 1987
- Correlation of Ibuprofen Bioavailability with Gastrointestinal Transit by Scintigraphic Monitoring of 171Er-Labeled Sustained-Release TabletsPharmaceutical Research, 1987
- Solid Dispersion Controlled Release: Effect of Particle Size, Compression Force and TemperatureDrug Development and Industrial Pharmacy, 1985
- The filling of molten and thixotropic formulations into hard gelatin capsulesJournal of Pharmacy and Pharmacology, 1980
- Dissolution Rates of High Energy Polyvinylpyrrolidone (PVP)-Sulfathiazole CoprecipitatesJournal of Pharmaceutical Sciences, 1969
- Interactions Between Pharmaceutical Compounds by Thermal MethodsJournal of Pharmaceutical Sciences, 1969